Savara
SVRA
#5743
Rank
S$1.50 B
Marketcap
S$7.37
Share price
3.55%
Change (1 day)
115.65%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -S$0.16 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$0.13 Billion a decrease over its 2023 earnings that were of -S$69.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.16 Billion25.59%
2024 -S$0.13 Billion75.29%
2023 -S$69.07 Million43.38%
2022 -S$48.17 Million-11.31%
2021 -S$54.31 Million-13.3%
2020 -S$62.65 Million-36.53%
2019 -S$98.7 Million13.76%
2018 -S$86.77 Million105.54%
2017 -S$42.22 Million34.11%
2016 -S$31.48 Million-37.43%
2015 -S$50.31 Million38.81%
2014 -S$36.24 Million33.62%
2013 -S$27.13 Million38.49%
2012 -S$19.59 Million24.59%
2011 -S$15.72 Million-36.5%
2010 -S$24.76 Million-3.14%
2009 -S$25.56 Million-23.28%
2008 -S$33.31 Million8.52%
2007 -S$30.7 Million-34.14%
2006 -S$46.61 Million184.43%
2005 -S$16.39 Million90.75%
2004 -S$8.6 Million190.35%
2003 -S$2.96 Million11.64%
2002 -S$2.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$22.93 Million-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA